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MECHANISMS OF ACTION OF ESE1, A NOVEL TRANSCRIPTIONAL
REGULATOR OF CARTILAGE REMODELING, IN MMP-13 REGULATION
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R.M. Borzì2, A. Facchini2, K.B. Marcu4,2, M.B. Goldring1
1Hosp. for Special Surgery, New York, NY; 2Istituti Ortopedici Rizzoli, Bologna,
Italy; 3Kagoshima Univ., Kagoshima, Japan; 4Stony Brook Univ., Stony Brook,
NY
Purpose: Matrix metalloproteinase (MMP)-13 plays a major role in car-
tilage degradation. MMP-13 expression and activity are up-regulated in
osteoarthritis (OA) cartilage as compared to non-OA cartilage. We previ-
ously reported that ELF3/ESE1 levels are higher in OA cartilage and that
ESE-1 transactivates the MMP13 promoter via a proximal highly conserved
ETS binding site. The aim of this study was to better deﬁne the mech-
anism/s and signalling pathways that modulate the ESE-1-driven MMP13
promoter activation in chondrocytes.
Methods: We investigated the contribution of ESE-1 to MMP-13 expression
by siRNA knock down (KD) transfection experiments in human primary
chondrocytes and real time PCR analysis of MMP-13 expression induced by
IL-1β. The response of the MMP13 promoter to ESE-1 was analyzed in lu-
ciferase reporter assays, after co-transfection of immortalized chondrocytes
with human MMP13 promoter constructs and expression vectors encoding
ESE-1, p38, JNK, ERK-1, MKK-6, MKK-7, MEK-1 and MKP-1. ESE-1 binding
to the MMP13 promoter was analyzed by chromatin immunoprecipitation
(ChIP) assays. IL-1β-induced ESE-1 nuclear translocation was addressed by
Western blotting analysis of cytoplasmic and nuclear fractions of human
immortalized chondrocytes.
Results: Real time PCR analysis revealed a signiﬁcant reduction of IL-
1β-induced MMP-13 mRNA levels associated with ESE-1 KD in human
primary chondrocytes. Luciferase reporter assays showed that MEK1/ERK1
overexpression enhanced ESE1-driven activities of the -1528/+27 and -
267/+27 MMP13 promoter constructs, whereas MKK6/p38 or MKK7/JNK
overexpression did not affect ESE-1 transactivation of MMP-13. Over-
expression of MKP-1 reduced both the ESE-1 activation of MMP13 and
also the MEK1/ERK1 enhancement of ESE-1-driven MMP13 activation.
Accordingly, pre-treatment with the MEK1/2 inhibitor, U0126, decreased
the MMP13 promoter activity induced by ESE-1 overexpression. Finally,
Western blotting analysis revealed that IL-1β stimulation induced ESE-1
nuclear translocation, which correlated with increased ESE-1 binding to the
endogenous MMP13 promoter, as addressed by ChIP assays.
Conclusions: The role of MMP-13 as a central factor for OA progression
has been highlighted by recent studies in Mmp13 knockout mice. We
previously reported that ESE-1 is a key factor in controlling MMP13 tran-
scription. ESE-1 belongs to the ETS family of transcription factors, which
are classic MAPK effectors in different tissues and cell types. Here, we
show that ESE-1 participates in the IL-1β-induced MMP-13 expression
and that IL-1β induces ESE-1 nuclear translocation and binding to the
MMP13 promoter. In addition, we show that the ESE1-driven transacti-
vation of MMP13 is enhanced by MEK1/ERK1. In chondrocytes, ERK1/2
phosphorylation is increased in vitro in response to IL-1β and in vivo in
OA cartilage, and MEK/ERK activation has been reported to participate in
the cytokine-induced MMP-13 expression. Therefore, ESE-1 could be one of
the effectors of the MEK/ERK pathway in controlling MMP-13 expression
in chondrocytes, and the relative contributions of the MEK/ERK/ESE1 axis
in OA with regard to MMP-13 expression and activity will merit further
investigation.
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TEMPORAL EXPRESSION AND TISSUE DISTRIBTUTION OF
INTERLEUKIN-1B IN TWO STRAINS OF GUINEA PIGS WITH VARYING
DEGREES OF SPONTANEOUS OSTEOARTHRITIS
K.S. Santangelo, G.J. Nuovo, E. Pieczarka, S.E. Weisbrode, A.L. Bertone
The Ohio State Univ., Columbus, OH
Purpose: Interleukin-1β (IL-1β) has been cited as a major cytokine involved
in OA-related joint degeneration but deﬁnitive characterization of its role
in vivo remains elusive. The objective of this study was to determine
the temporal expression and tissue distribution of IL-1β in whole knee
joints harvested from OA-prone and resistant guinea pigs via immuno-
histochemistry (IHC). Two main hypotheses were tested: 1) differences in
IL-1β expression would be detected in joint tissue of OA-prone animals
during the course of disease progression; and 2) IL-1β expression patterns
in OA-prone animals would differ from that of OA-resistant animals.
Methods: OA-prone Hartley (N=24) and OA-resistant Strain 13 (N=24)
guinea pigs were collected at 60, 120, 180, 240, 360, and 480 days of age
(N=4 per strain per time point). IHC was performed on paraﬃn-embedded
sections of whole knee joints and the distribution of IL-1β expression in
all tissue was both descriptively described and scored. OA was graded on
toluidine blue stained coronal sections using Mankin criteria with modiﬁ-
cations speciﬁc for the guinea pig. Data was reported as median and range,
and statistical analysis was performed using the Kruskal-Wallis one-way
analysis of variance by ranks followed by Dunn’s post test.
Results: Median OA scores for both strains increased from 60 to 480
days of age, and a statistically higher score (p≤0.01) was found in Hartley
animals by 480 days of age. The tissue distribution and intensity of IL-1β
immunostaining was consistent within the knee joint organs for each group
(strain and age) examined, allowing identiﬁcation of differing expression
patterns in cartilage, synovium, menisci, and subchondral bone both within
and between guinea pig models over time. The most striking ﬁnding was
persistent IL-1β expression in all aforementioned tissues in Hartley guinea
pigs at 120 and 180 days of age, while Strain 13 animals demonstrated a
signiﬁcant (p≤0.05) and marked reduction in positive cells and/or matrix at
these same time points. Further, when present, the distribution of positive
protein detection often varied within tissue type for each guinea pig strain.
For example, descriptive regional differences in weight-bearing cartilage
were discerned between guinea pig strains at 360 and 480 days of age.
Immunostaining in the cartilage of Hartley guinea pigs at these time points
was restricted to midline and medial or lateral regions, while positive
cells and/or matrix of Strain 13 animals were present only in central
regions.
Conclusions: This study provides evidence that IL-1β continues to be
an important biomarker relevant to the development and progression of
OA. Although these ﬁndings do not directly explicate a cause-and-effect
relationship between IL-1β and OA, data is provided as to a window of time
when targeted cytokine reduction and/or blockade may prove effective in
elucidating such a correlation and identifying its mechanistic components.
In this vein, in vitro and in vivo investigations are underway to determine
the effects that reduction of IL-1β via RNA interference may have on other
key mediators implicated in OA. Alternately, should IL-1β, itself, prove to
represent only a secondary response to a more primary insult propagating
OA pathogenesis, groundwork has been laid to hone in on the offending
pathway.
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THE COMBINATION OF IL-4 AND IL-10 PROTECTS AGAINST
BLOOD-INDUCED CARTILAGE DAMAGE
M.E. van Meegeren1,2, S.C. Mastbergen1, N.W. Jansen1,2, G. Roosendaal2,
F.P. Lafeber1
1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht, Utrecht,
Netherlands; 2Haematology and Van Creveld Clinic, Univ. Med. Ctr. Utrecht,
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Purpose: Exposure of cartilage to blood can occur after joint trauma, during
or after major joint surgery, or in hemophilia patients. This ultimately
leads to joint damage, having both the inﬂammatory characteristics of
rheumatoid arthritis and the degenerative characteristics of osteoarthritis.
It was shown that in vitro exposure of cartilage to 50% v/v blood for 4
days, the supposed natural evacuation time of blood from a joint, leads to
98% inhibition of cartilage matrix synthesis. Even after a recovery period
of 12 days (in the absence of blood) cartilage matrix synthesis is still
inhibited by 78%. We have previously demonstrated that interleukin (IL)-10
limits in vitro blood-induced cartilage damage. In addition, IL-4 has been
suggested to have cartilage protective properties. Hence our aim was to
study whether IL-4 can support IL-10 in the prevention of blood-induced
cartilage damage.
Methods: Human full thickness articular cartilage explants were cultured
for 4 days in the presence or absence of 50% v/v homologous blood. IL-4
was added in concentrations of 0, 1, 3, 10, 30, or 100 ng/ml during blood
exposure. A combination of IL-4 and IL-10 was added in a concentration
of 100 ng/ml. After 4 days the medium was refreshed and cartilage was
cultured for an additional 12 days in the absence of additives to determine
long-term effects of short-term blood-exposure and treatment. Cartilage
matrix turnover, in terms of proteoglycan synthesis, -release, and -content,
was determined at day 16.
